relapsed non-Hodgkin lymphoma by autologous stem cell transplantation in patients with poor-risk or combination with high-dose etoposide and cyclophosphamide followed A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan inJasmine Zain,Christine White,Andrew Raubitschek,Roberto Rodriguez,Firoozeh Sahebi,Eileen Smith,David Snyder,Anthony Stein,Neil Kogut,Ryotaro Nakamura,Margaret O'Donnell,Pablo Parker,Leslie Popplewell,Vinod Pullarkat,Cheuk Kwok,Dave Yamauchi,Anne-Line Anderson,Peter Falk,Amrita Krishnan,Mark Kirschbaum,Auayporn Nademanee,Stephen Forman,Arturo Molina,Henry Fung,David Smith,Andy Dagismsra（2010）引用 23|浏览44暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
